Dae-Kee Kim is a professor at the department of pharmacy, college of pharmacy and is a prominent professor in the field of new drug development. He received his ph.D. in medicinal chemistry at the State University of New York at Buffalo, USA, and he is currently doing his research to develop new anticancer and antifibrotic drugs.  He successfully commercialized the 1st new drug in Korea, an anticancer platinum complex 'Sunpla' in 1999 and the 13th new drug in Korea, an anti-erectile dysfuntion drug 'Mbix' in 2007. He developed 'Vactosertib (EW-7197)' as a potential anticancer/antifibrotic agent,  and nine 1b/2a clinical trials  are currently oning in USA and Korea. He has published 120 articles in SCI journals.